OPPORTUNITY
The opportunity · what the numbers say it is worth
Our framework reads AVOID — it trades above our $5,052.24 fair value estimate, 19.10% revenue growth.
Read at
$7,312.00
36.36 P/E · 27.58 fwd
Our fair value
$5,052.24
31% premium
Analyst target (avg)
$7,864.00
+8% to current
Target low $6,200.00Analyst target rangeTarget high $8,862.00
▲ current $7,312.00 · | average target
Price history & projections · where it has been, where the models see it going
The valuation journey · where the price sits against fair value and the Street
Green marks levels above today's price, red below; the shaded band is the gap between the price and our fair value.
Reading the gap · Our more conservative model reads it as fully-to-richly valued here, while the Street is more bullish — a quality-at-a-fair-price name rather than a deep-value one.
Fair value and rating are our own model estimates; target range reflects third-party analyst estimates. Analysis, not advice.
SCREEN
The values screen, explained · five checks, plain English
This company clears both standards. There are two widely recognised ways to check whether a company is suitable for a Muslim investor. Here is how it did on each:
The common standard · AAOIFI
Used by most halal investing apps
✓ PASSES
Our stricter standard · asset-based
The one Titan applies
✓ PASSES
What these two standards are, and how they differ →
-
Business activity
Its core business isn't built on prohibited lines — no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
-
Debt load
Interest-bearing debt is just 1.6% of its assets, well under the one-third ceiling — it does not run on borrowed money.
Pass
-
Interest-bearing cash
Cash held in interest-bearing accounts and securities is 20.2% of assets, under the one-third limit.
Pass
-
Receivables
Money owed to the company is 1.8% of assets, under the 49% limit.
Pass
-
Revenue purity
Only 2.1% of revenue comes from non-compliant sources — under the 5% line.
Pass
Every security is read against two recognised standards: our stricter asset-based screen (ratios measured against total assets) and the more widely used market-value standard (measured against market capitalisation). Where they agree we say so plainly; where they part ways — almost always on the debt check — we show both readings and mark it, because that disagreement is the finding, not a fault. We report the score; you and your scholar make the call.
PLAIN
The business, in plain words · what the numbers mean
Why it gives us pause
At 27.6x forward earnings, the price already runs ahead of the business. It trades 31% above our $5,052.24 fair value, so you would be buying at a premium, not a discount.
The risks · The things to watch: its business and earnings are exposed to India and to currency swings; it carries a real debt load, which raises the stakes if revenue slips.
Plain-English interpretation of our own screen data. Analysis, not advice.
JOURNAL
The dated journal · newest first, never edited
2026-07-30
Markup $7,312.00
+0.0% Entry 10
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 5% above its long-term trend line with momentum reading neutral. Our forward projection puts the odds of a 10% gain over the next month near 20%. The street (34 analysts) rates it buy, with a mean price target of $7795. It reported earnings in this window, a natural checkpoint for the thesis.
2026-07-28
Markup $7,312.00
+0.0% Entry 9
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 5% above its long-term trend line with momentum reading neutral. Our forward projection puts the odds of a 10% gain over the next month near 20%. The street (34 analysts) rates it buy, with a mean price target of $7795. It reported earnings in this window, a natural checkpoint for the thesis.
2026-07-27
Markup $7,312.00
+0.0% Entry 8
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 5% above its long-term trend line with momentum reading neutral. Our forward projection puts the odds of a 10% gain over the next month near 20%. The street (34 analysts) rates it buy, with a mean price target of $7795. It reported earnings in this window, a natural checkpoint for the thesis.
2026-07-26
Markup $7,312.00
+0.0% Entry 7
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 5% above its long-term trend line with momentum reading neutral. Our forward projection puts the odds of a 10% gain over the next month near 20%. The street (34 analysts) rates it buy, with a mean price target of $7795. It reported earnings in this window, a natural checkpoint for the thesis.
2026-07-25
Markup $7,312.00
+0.0% Entry 6
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 5% above its long-term trend line with momentum reading neutral. Our forward projection puts the odds of a 10% gain over the next month near 20%. The street (34 analysts) rates it buy, with a mean price target of $7795. It reported earnings in this window, a natural checkpoint for the thesis.
2026-07-24
Markup $7,312.00
+0.0% Entry 5
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 5% above its long-term trend line with momentum reading neutral. Our forward projection puts the odds of a 10% gain over the next month near 20%. The street (34 analysts) rates it buy, with a mean price target of $7795. It reported earnings in this window, a natural checkpoint for the thesis.
2026-07-23
Markup $7,312.00
+0.0% Entry 4
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 5% above its long-term trend line with momentum reading neutral. Our forward projection puts the odds of a 10% gain over the next month near 20%. The street (34 analysts) rates it buy, with a mean price target of $7795. It reported earnings in this window, a natural checkpoint for the thesis.
2026-07-18
Markup $7,312.00
+0.0% Entry 3
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 5% above its long-term trend line with momentum reading neutral. Our forward projection puts the odds of a 10% gain over the next month near 20%. The street (34 analysts) rates it buy, with a mean price target of $7795.
2026-07-03
Markup $7,312.00
+0.0% Entry 2
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns.
2026-07-02
Markup $7,312.00
Entry 1
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.